Weekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years agoWeekly News Round-up – 15/1/21
In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...
4 years ago
Weekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years agoWeekly News Round-up – 8/1/21
Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...
4 years ago
Weekly News Round-up – 11/9/20
In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...
4 years agoWeekly News Round-up – 11/9/20
In the news this week, Oxford University and AstraZeneca have temporarily suspended their joint COVID-19 vaccine trials over safety fears as a subject falls ill. In other news, GSK and Sanofi begin their own COVID trials, and a group of...
4 years ago
Weekly News Round-Up – 14/8/20
In the news this week, the race for a vaccine begins to near its conclusion as the U.S. and U.K. continue to buy up supplies of promising vaccines, and Moderna comes under criticism for its steep prices that make the...
4 years agoWeekly News Round-Up – 14/8/20
In the news this week, the race for a vaccine begins to near its conclusion as the U.S. and U.K. continue to buy up supplies of promising vaccines, and Moderna comes under criticism for its steep prices that make the...
4 years ago
Weekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
4 years agoWeekly News Round-up – 7/8/20
In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested...
4 years ago
Weekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
4 years agoWeekly News Round-up – 17/7/20
In the news this week, despite significant alarms recently that GSK’s belantamab mafodotin could endanger patients’ eyes, the multiple myeloma drug has been approved by expert advisers. In other news, Novartis promises to make no profit from 15 of its COVID...
4 years ago
Weekly News Round-up – 10/7/20
In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....
4 years agoWeekly News Round-up – 10/7/20
In the news this week, the Trump Administration has made another deal to acquire all initial doses of a potential COVID-19 drug, in this case Regeneron’s REGN-COV2. This follows their acquisition of the first batches of Gilead’s remdesivir last week....
4 years ago
Weekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years agoWeekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years ago
Weekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
4 years agoWeekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
4 years ago
Weekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
4 years agoWeekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
4 years ago